Epigenetix

Epigenetix

Biotechnology, 1004 BRKS Ln, Delray Beach, Florida, 33483, United States, 11-50 Employees

epigenetix.com

  • twitter
  • LinkedIn

phone no Phone Number: +19*********

Who is EPIGENETIX

Epigenetix is a clinical stage pharma company with a first-in-class oral cancer drug about to begin phase on trials at 5 leading US cancer centers. We will include patients with prostate ...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from EPIGENETIX

Epigenetix Org Chart and Mapping

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Epigenetix

Answer: Epigenetix's headquarters are located at 1004 BRKS Ln, Delray Beach, Florida, 33483, United States

Answer: Epigenetix's phone number is +19*********

Answer: Epigenetix's official website is https://epigenetix.com

Answer: Epigenetix's revenue is Under $1 Million

Answer: Epigenetix's SIC: 2834

Answer: Epigenetix has 11-50 employees

Answer: Epigenetix is in Biotechnology

Answer: Epigenetix contact info: Phone number: +19********* Website: https://epigenetix.com

Answer: Epigenetix is a clinical stage pharma company with a first-in-class oral cancer drug about to begin phase on trials at 5 leading US cancer centers. We will include patients with prostate cancer, pancreatic cancer, breast cancer, sarcoma, NUT carcinoma and other cancers where our drug has shown unprecedented anti-cancer activity. Our drug was selected among many other drug candidates to potently inhibit three different validated cancer drug targets: p300/CBP + BRD4+ CECR2. Treatment results in elimination of both the tumor itself as well as associated metastases. This powerful drug fights cancer in multiple ways: (1) by eradicating tumor cells directly (cytotoxic therapy), (2) by unleashing the bodys immune system (immunotherapy), and (3) by inhibiting cancer-inducing male and female hormone actions (hormone therapy). While presently pursued as monotherapy, synergy with checkpoint inhibitors, PARP inhibitors, CDK4/6 inhibitors as well as epigenetic drugs, such as EZH2 inhibitors ,has been shown preclinically.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access